Clinical Trials Logo

Clinical Trial Details — Status: Not yet recruiting

Administrative data

NCT number NCT05378438
Other study ID # 39/2022
Secondary ID
Status Not yet recruiting
Phase N/A
First received
Last updated
Start date July 15, 2022
Est. completion date April 17, 2023

Study information

Verified date July 2022
Source Nepal Health Research Council
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

This study is designed to assess the impact of the first introduction of microscope-based health education on people's attitude and practice towards disease prevention in Nepal, measured by vaccine acceptance rate. Such health education has an important role to play in communities where vaccine acceptance is low.


Recruitment information / eligibility

Status Not yet recruiting
Enrollment 1252
Est. completion date April 17, 2023
Est. primary completion date September 30, 2022
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria: - People aged 18 years or older who are resident of the study target area - People who stayed at least for 6 months on the area of study - People who agrees with the procedure of study and follow ups visits - People who provide consent for their participation will be recruited in the study. Exclusion Criteria: - People under 18 years of age will not be enrolled into study due to their limitation of understanding and implementation of the content of workshop given as intervention. - People who do not wish to participate in the trial - Those with currently ongoing court hearing and deprive of freedom will not be enrolled for the study.

Study Design


Related Conditions & MeSH terms


Intervention

Other:
Microbe literacy Program in the form of workshop
Two to Three hours of workshop on microbe literacy will be conducted as an intervention. Workshop includes discussion on various common microorganisms causing diseases, their sources, relationship with surroundings and management. Prime focus of the session will be on management via treatments and risk reduction via vaccination.

Locations

Country Name City State
Nepal Nepal Health Research Council Kathmandu Bagmati

Sponsors (3)

Lead Sponsor Collaborator
Nepal Health Research Council Microbe Literacy Initiative, Partnership for Sustainable Development Nepal (PSDNepal)

Country where clinical trial is conducted

Nepal, 

Outcome

Type Measure Description Time frame Safety issue
Primary Differential vaccine acceptance rates between intervention and control group Data will be collected for baseline as well as post intervention after 3 months of workshop. For both the intervention and control group, number of vaccinated among the participants for provided COVID-19 vaccine and Typhoid vaccine will be made. Comparative analysis will be made in both the study groups before and after the intervention program. Within 3 months of intervention
See also
  Status Clinical Trial Phase
Completed NCT05875779 - Peer Education as a Strategy to Promote Vaccine Acceptance N/A
Completed NCT02196454 - Video to Promote HPV Vaccination N/A